Chapter 6 A Journey with Bleeding Time Factor

Comprehensive Biochemistry

Volumn 45, Issue , 2007, Pages 209-255

  Blombäck, Birger ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

ADAMTS 13.; factorVIII; multimer; platelets; Von Willebrand factor; VWD; VWF

Indexed keywords

EID: 44449172526     PISSN: 00698032     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0069-8032(07)45006-9     Document Type: Review

References (140)

1. von Willebrand E.A. Hereditär pseudohämofili. Finska Läkaresällskapets Handlingar LXVII (1926) 87-112
2. von Willebrand, E.A. (1931) Über hereditäre Pseudohämophilie. Acta Med. Scand. LXXVI(fasc. IV-VI), 521-550 - An addendum refers to a similar case with ascent for three generations (Acta Med. Scand. 72, 104 (1929).
3. von Willebrand E.A., Jürgens R., and Dahlberg U. Konstitutionell trombopati, en ny ärftlig blödarsjukdom. Finska Läkaresällskapets Handlingar LXXVI (1934) 193-232
4. Alexander B., and Goldstein R. Dual hemostatic Defect in pseudohemophilia. J. Clin. Invest. 32 (1953) 551
5. Larrieu M.-J., and Soulier J.P. Déficit en facteur antihémophilique A chez une fille, associé a un trouble du saignement. Rev. Hemat. 8 (1953) 361-370
6. Blombäck B., and Blombäck M. Purification of human and bovine Fibrinogen. Ark. Kemi 10 (1956) 415-443
7. Nilsson I.M., Blombäck B., Blombäck M., and Svennerud S. Kvinnlig hämofili och dess behandling med humant antihämofiliglobulin. Nordisk Medicin 56 (1956) 1654-1662
8. Nilsson I.M., Blombäck M., and von Franken I. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med. Scand. CLIX fasc. 1 (1957) 35-57
9. Nilsson I.M., Blombäck M., Jorpes E., Blombäck B., and Johansson S.-A. Von Willebrand's disease and its correction with human plasma fraction I-O. Acta Med. Scand. CLIX fasc. III (1957) 179-188
10. Blombäck, B. (1958) Studies on fibrinogen and antihaemophilic globulin, XIIth Conference of the Protein Foundation on blood cells and plasma proteins, Albany, NY, November 1957. Vox Sang., 3, 58.
11. Nilsson I.M., Blombäck M., and Blombäck B. v. Willebrand's disease in Sweden: its pathogenesis and treatment. Acta Med. Scand. 164 fasc. 3 (1959) 263-278
12. Nilsson I.M., and Blombäck M. von Willebrand's disease in Sweden - occurrence, pathogenesis and treatment. Thromb. Diath. Haemorrhagica IX Suppl. 2 (1962) 103-118
13. Blombäck M., Blombäck B., and Nilsson I.M. Response to fractions in von Willebrand's disease. In: Brinkhous K.M. (Ed). The Haemophilias (1964), University North Carolina Press, Chapel Hill 286-294
14. Weiss H.J. The use of plasma and plasma fractions in the treatment of a patient with von Willebrand's disease. Vox Sang. 7 (1962) 267-280
15. Van Creveld S., and Mochtar I.A. Von Willebrand's disease - a plasma deficiency cause of the prolonged bleeding time. Ann. Paediatr. 194 (1960) 37-46
16. Cornu P., Larrieu M.-J., Caen J., and Bernard J. Données nouvelles concernant la maladie de Willebrand (Angiohémophilie). Rev. Franç. Études. Clin. Biol. 5 (1960) 614-620
17. Cornu P., Larrieu M.-J., Caen J., and Bernard J. Transfusion studies in von Willebrand's disease: effect on bleeding time and factor VIII. Brit J. Haematol. 9 (1963) 189-202
18. Biggs, R. and Macfarlane, R.G. (eds.) (1962) von Willebrand's disease. In Human Blood Coagulation and Its Disorders, p. 280. Oxford, Blackwell.
19. Borchgrevink C.F. Platelet adhesion in vivo in patients with bleeding disorders. Acta Med. Scand. 170 fasc. 2 (1961) 231-243
20. Salzman E.W. Measurement of platelet adhesiveness: a simple in vitro technique demonstrating an abnormality in von Willebrand's disease. J. Lab. Clin. Med. 62 (1963) 724-735
21. Zucker M.B. In vitro abnormality of the blood in von Willebrand's disease correctable by normal plasma. Nature 197 (1963) 601-602
22. O'Brien J.R., and Heywood J.B. Some interactions between human platelets and glass: von Willebrand's disease compared with normal. J. Clin. Pathol. 20 (1967) 56-64
23. Meyer D., and Larrieu M.-J. Von Willebrand factor and platelet adhesiveness. J. Clin. Pathol. 23 (1970) 228-231
24. Stormorken H. The defect in von Willebrand's disease. In: Johnson S.A., and Seegers W.H. (Eds). Physiology of Hemostasis and Thrombosis (1967), Charles C. Thomas Publisher, Springfield, Illinois, USA 179-200
25. Hovig, T. and Stormorken, H. (1974) Ultrastructural studies on the platelet plug formation in bleeding time wounds from normal individuals and patients with von Willebrand's disease. Acta Path. Microbiol. Scand., Sect. A, Suppl. 248: 105-122.
26. Zimmerman T.S., Ratnoff O.D., and Powell A.E. Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease. J. Clin. Invest. 50 (1971) 244-254
27. Bloom A.L., Peake I.R., and Giddings J.C. The precence and reactions of high and lower-molecular-weight procoagulant factor VIII in the plasma of patients with von Willebrand's disease after treatment: significance for a structural hypothesis for factor VIII. Thromb. Res. 3 (1973) 389-404
28. Zimmerman T.S., and Edgington T.S. Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities. J. Exp. Med. 138 (1973) 1015-1020
29. Owen W.G., and Wagner R.H. Antihaemophilic factor: separation of an active fragment following dissociation by salts or detergents. Thromb. Diath. Haemorrh. 27 (1972) 502-515
30. Olson J.D., Brockway W.J., Fass D.N., Bowie E.J.W., and Mann K.G. Purification of porcine and human ristocetin-Willebrand factor. J. Lab. Clin. Med. 89 (1977) 1278-1294
31. Jaffe E.A., Hoyer L.W., and Nachman R.L. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc. Nat. Acad. Sci. U.S.A. 71 (1974) 1906-1909
32. Nachman R., Levine R., and Jaffe E.A. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J. Clin. Invest. 60 (1977) 914-921
33. Holmberg L., and Ljung R. Purification of factor VIII:C by antigen-antibody chromatography. Thromb. Res. 12 (1978) 667-675
34. Tuddenham E.G.D., Trabold N.C., Collins J.A., and Hoyer L.W. The properties of factor VIII coagulant activity prepared by immunoadsorbent chromatography. J. Lab. Clin. Med. 93 (1979) 40-53
35. Vehar G.A., and Davie E.W. Preparation and properties of bovine factor VIII (Antihemophilic factor). Biochemistry 19 (1980) 401-410
36. Fay P.J., Chavin S.I., Schroeder D., Young F.E., and Marder V.J. Purification and characterization of a highly purified human factor VIII consisting of a single type of polypeptide chain. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 7200-7204
37. Howard M.A., and Firkin B.G. Ristocetin - a new tool in the investigation of platelet aggregation. Thromb. Diath. Haemorrh. 26 (1971) 362-369
38. Counts R.B., Paskell S.L., and Elgee S.K. Disulfide bonds and the quaternary structure of Factor VIII/von Willebrand factor. J. Clin. Invest. 62 (1978) 702-709
39. Meyer D., Obert B., Pietu G., Lavergne J.M., and Zimmerman T.S. Multimeric structure of factorVIII/von Willebrand factor in von Willebrand's disease. J. Lab. Clin. Med. 95 (1980) 590-602
40. Wagner D.D., and Marder V.J. Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and the intracellular localization. J. Cell Biol. 99 (1984) 2123-2130
41. Thorell L., and Blombäck B. Purification of the factor VIII complex. Thromb. Res. 35 (1984) 431-450
42. Thorell L., Blombäck M., and Blombäck B. An in vivo study of a new factor VIII high purity preparation. Thromb. Res. 31 (1983) 375-385
43. Schwarz H.P., Schlokat U., Mitterer A., Váradi K., Gritsch H., Muchitsch E.-M., Auer W., Pichler L., Dorner F., and Turecek P.L. Recombinant von Willebrand factor - insight into structure and function through infusion studies in animals with severe von Willebrand disease. Semin. Thromb. Hemost. 28 (2002) 215-225
44. Sakariassen K.S., Bolhuis P.A., Blombäck M., Thorell L., Blombäck B., and Sixma J.J. Association between bleeding time and platelet adherence to artery subendothelium. Thromb. Haemostasis 52 (1984) 144-147
45. Hessel B., Jörnvall H., Thorell L., Söderman S., Larsson U., Egberg N., Blombäck B., and Holmgren A. Structure-function relationships of human factor VIII complex studied by thioredoxin dependent disulfide reduction. Thromb. Res. 35 (1984) 637-651
46. Sadler J.E., Shelton-Inloes B.B., Sorace J.M., Harlan J.M., Titani K., and Davie E.W. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 6394-6398
47. Verweij C.L., Diergaarde P.J., Hart M., and Pannekoek H. Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO J. 5 (1986) 1839-1847
48. Montgomery R.R., and Zimmerman T.S. von Willebrand's disease antigen II: a new plasma and platelet antigen deficient in severe von Willebrand's disease. J. Clin. Invest. 61 (1978) 1498-1507
49. Chopek M.W., Girma J.-P., Fujikawa K., Davie E.W., and Titani K. Human von Willebrand factor: a multivalent protein composed of identical subunits. Biochemistry 25 (1986) 3146-3155
50. Girma J.-P., Chopek M.W., Titani K., and Davie E.W. Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domain. Biochemistry 25 (1986) 3156-3163
51. Titani K., Kumar S., Takio K., Ericsson L.H., Wade R.D., Ashida K., Walsh K.A., Chopek M.W., Sadler J.E., and Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochemistry 25 (1986) 3171-3184
52. Vermylen J., Donati M.B., de Gaetano G., and Verstraete M. Aggregation of human platelets by bovine or human factor VIII: role of carbohydrate side chains. Nature 244 (1973) 167-168
53. Katsumi A., Tuley E.A., Bodó I., and Sadler J.E. Localization of disulfide bonds in the cystine knot domain of human von Willebrand factor. J. Biol. Chem. 275 (2000) 25585-25594
54. Emsley J., Cruz M., Handin R., and Liddington R. Crystal structure of the von Willeband factor A1 domain and implications for the binding of platelet glycoprotein Ib. J. Biol. Chem. 273 (1998) 10396-10401
55. Sadler J.E. Biochemistry and genetics of von Willebrand factor. Annu. Rev. Biochem. 67 (1998) 395-424
56. Fowler W.E., Fretto L.J., Hamilton K.K., Erickson H.P., and McKee P.A. Substructure of human von Willebrand factor. J. Clin. Invest. 76 (1985) 1491-1500
57. Fretto L.J., Fowler W.E., McCaslin D.R., Erickson H.P., and McKee P.A. Substructure of human von Willebrand factor: proteolysis by V8 and characterization of two functional domains. J. Biol. Chem. 261 (1986) 15679-15689
58. Wagner D.D., Lawrence S.O., Ohlsson-Wilhelm B.M., Fay P.J., and Marder V.J. Topology and order of formation of interchain disulfide bonds in von Willebrand factor. Blood 69 (1987) 27-32
59. Siedlecki C.A., Lestini B.J., Kottke-Marchant K., Eppell S.J., Wilson D.L., and Marchant R.E. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 88 (1996) 2939-2950
60. Girma J.P., Takahashi Y., Yoshioka A., Diaz J., and Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb. Haemostasis 64 (1990) 326-332
61. Verweij C.L., Hart M., and Pannekoek H. Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWF multimer formation. EMBO J. 6 (1987) 2885-2890
62. Wise R.J., Dorner A.J., Krane M., Pittman D.D., and Kaufman R.J. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J. Biol. Chem. 266 (1991) 21948-21955
63. Loscalzo J., Fisch M., and Handin1 R.I. Solution studies of the quaternary structure and assembly of human von Willebrand factor. Biochemistry 24 (1985) 4468-4475
64. Wagner D.D., Olmsted J.B., and Marder V.J. Immunolocalization of von Willebrand Protein in Weibel-Palade bodies of human endothelial cells. J. Cell Biol. 95 (1982) 355-360
65. Zucker M.B., Soberano M.E., Johnson A.J., Fulton A.J., Kowalski S., and Adler M. The in vitro association of antihemophilic factor and von Willebrand factor. Thromb. Haemostasis 49 (1983) 37-41
66. Weiss H.J., Sussman I.I., and Hoyer L.W. Stabilization of factor VIII in plasma by the von Willebrand factor. J. Clin. Invest. 60 (1977) 390-404
67. Tuddenham E.G.D., Lane R.S., Rotblat F., Johnson A.J., Snape T.J., Middleton S., and Kernoff P.B.A. Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Brit. J. Haematol. 52 (1982) 259-267
68. Brinkhous K.M., Sandberg H., Garris J.B., Mattson C., Palm M., Griggs T., and Read M.S. Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 8752-8756
69. Foster P.A., Fulcher C.A., Marti T., Titani K., and Zimmerman T.S. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J. Biol. Chem. 262 (1987) 8443-8446
70. Vlot A.J., Koppelman S.J., Meijers J.C.M., Damas C., van den Berg H.M., Bouma B.N., Sixma J.J., and Willems G.M. Kinetics of factor VIII-von Willebrand factor association. Blood 87 (1996) 1809-1816
71. Nesheim M., Pittman D.D., Giles A.R., Fass D.N., Wang J.H., Slonosky D., and Kaufman R.J. The effect of plasma von Villebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J. Biol. Chem. 266 (1991) 17815-17820
72. Weiss H.J., Turitto V.T., and Baumgartner H.R. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate-dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J. Lab. Clin. Med. 92 (1978) 750-764
73. Baumgartner H.R., Tschopp T.B., and Meyer D. Shear rate dependent inhibition of platelet adhesion and aggregation on collagen surfaces by antibodies to human factor VIII/von Willebrand factor. Br. J. Haematol. 44 (1980) 127-139
74. Baumgartner H.R., Tschopp T.B., and Weiss H.J. Platelet interaction with collagen fibrils in flowing blood. II. Impaired adhesion-aggregation in bleeding disorders: a comparison with subendothelium. Thromb. Haemostasis 37 (1977) 17-28
75. Nyman D. von Willebrand factor dependent platelet aggregation and adsorption of factor VIII related antigen by collagen. Thromb. Res. 17 (1980) 209-214
76. Sakariassen K.S., Bolhuis P.A., and Sixma J.J. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 279 (1979) 636-638
77. Rand J.H., Sussman I.I., Gordon R.E., Chu S.V., and Solomon V. Localization of factor VIII-related antigen in human vascular subendothelium. Blood 55 (1980) 752-756
78. Stel H.V., Sakariassen K.S., de Groot P.G., van Mourik J.A., and Sixma J.J. Von Willebrand factor in the vessel wall mediates platelet adherence. Blood 65 (1985) 85-90
79. Sakariassen K.S., Fressinaud E., Girma J.-P., Baumgartner H.R., and Meyer D. Mediation of platelet adhesion to fibrillar collagen in flowing blood by a proteolytic fragment of human von Willebrand factor. Blood 67 (1986) 1515-1518
80. Savage B., Sixma J.J., and Ruggeri Z.M. Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 425-430
81. Jenkins C.S.P., Phillips D.R., Clemetson K.J., Meyer D., Larrieu M.-J., and Lüscher E.F. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation: studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J. Clin. Invest. 57 (1976) 112-124
82. Okumura T., Lombart C., and Jamieson G.A. Platelet glycocalicin. II. Purification and characterization. J. Biol. Chem. 251 (1976) 5950-5955
83. Solum N.O., Hagen I., Filion-Myklebust C., and Stabaek T. Platelet glycocalicin: its membrane association and solubilization in aqueous media. Biochim. Biophys. Acta 597 (1980) 235-246
84. Clemetson K.J., Naim H.Y., and Lüscher E.F. Relationship between glycocalicin and glycoprotein Ib of human platelets. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 2712-2716
85. Ruan C., Tobelem G., McMichael A.J., Drouet L., Legrand Y., Degos L., Kieffer N., Lee H., and Caen J.P. Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br. J. Haematol. 49 (1981) 511-519
86. Sakariassen K.S., Nievelstein P.F.E.M., Coller B.S., and Sixma J.J. The role of platelet membrane glycoproteins Ib and IIb+IIIa in platelet adherence to human artery subendothelium. Br. J. Haematol. 63 (1986) 681-691
87. Turitto V.T., Weiss H.J., and Baumgartner H.R. Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion. J. Clin. Invest. 74 (1984) 1730-1740
88. Ikeda Y., Handa M., Kawano K., Kamata T., Murata M., Araki Y., Anbo H., Kawai Y., Watanabe K., Itagaki I., Sakai K., and Ruggeri Z.M. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J. Clin. Invest. 87 (1991) 1234-1240
89. Alevriadou B.R., Moake J.L., Turner N.A., Ruggeri Z.M., Folie B.J., Phillips M.D., Schreiber A.B., Hrinda M.E., and McIntire L.V. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 81 (1993) 1263-1276
90. Savage B., Almus-Jacobs F., and Ruggeri Z.M. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 94 (1998) 657-666
91. Piétu G., Cherel G., Margurie G., and Meyer D. Inhibition of von Willebrand factor-platelet interaction by fibrinogen. Nature 308 (1984) 648-649
92. Fellowes A.P., Brennan S.O., Holme R., Stormorken H., Brosstad F.R., and George P.M. Homozygous truncation of the fibrinogen Aα chain within the coiled coil causes congenital afibrinogenemia. Blood 96 (2000) 773-775
93. Bloom A.L., Giddings J.C., and Wilks C.J. Factor VIII on the vascular intima: possible importance in haemostasis and thrombosis. Nature New Biol. 241 (1973) 217-219
94. Holmberg L., Mannucci P.M., Turesson I., Ruggeri Z.M., and Nilsson I.M. Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A. Scand. J. Haematol. 13 (1974) 33-38
95. André P., Denis C.V., Ware J., Saffaripour S., Hynes R.O., Ruggeri Z.M., and Wagner D.D. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 96 (2000) 3322-3328
96. Sobel M., Soler D.F., Kermode J.C., and Harris R.B. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J. Biol. Chem. 267 (1992) 8857-8862
97. Rastegar-Lari G., Villoutreix B.O., Ribba A.-S., Legendre P., Meyer D., and Baruch D. Two clusters of charged residues located in the electropositive face of Von Willebrand factor A1 domain are essential for heparin binding. Biochemistry 41 (2002) 6668-6678
98. Zhang Z.P., Blombäck M., Nyman D., and Anvret M. Mutations of von Willebrand factor gene in families with von Willebrand disease in the Åland Islands. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7937-7940
99. Zhang Z., Lindstedt M., Blombäck M., and Anvret M. Effects of the mutant von Willebrand factor gene in von Willebrand disease. Hum. Genet. 96 (1995) 388-394
100. Schneppenheim R., Budde U., and Ruggeri Z.M. A molecular approach to the classification of von Willebrand disease. Best Pract. Res. Clin. Haematol. 14 (2001) 281-298
101. Sadler J.E. New concepts in von Willwbrand disease. Annu. Rev. Med. 56 (2005) 173-191
102. Peake I.R., Bloom A.L., and Giddings J.C. Inherited variants of factor VIII-related protein in von Willebrand's disease. N. Engl. J. Med. 291 (1974) 113-117
103. Zimmerman T.S., Dent J.A., Ruggeri Z.M., and Nannini L.H. Subunit composition of plasma von Willebrand factor. Cleavage is present in nomal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (Types IIC, IID and IIE). J. Clin Invest. 77 (1986) 947-951
104. Tsai H.-M., Sussman I.I., Ginsburg D., Lankhof H., Sixma J.J., and Nagel R.L. Proteolytic cleavage of recombinant Type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-I. Blood 89 (1997) 1954-1962
105. Ruggeri Z.M., Pareti F.I., Mannucci P.M., Ciavarella N., and Zimmerman T.S. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N. Engl. J. Med. 302 (1980) 1047-1051
106. Holmberg L., Dent J.A., Schneppenheim R., Budde U., Ware J., and Ruggeri Z.M. von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure. J. Clin. Invest. 91 (1993) 2169-2177
107. Ribba A.S., Christophe O., Derlon A., Cherel G., Siguret V., Lavergne J.M., Girma J.P., Meyer D., and Pietu G. Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease. Blood 83 (1994) 833-841
108. Nishino M., Girma J.-P., Rothschild C., Fressinaud E., and Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 74 (1989) 1591-1599
109. Hilbert, L., Jorieux, S., Proulle, V., Favier, R., Goudemand, J., Parquet, A., Meyer, D., Fressinaud, E., Mazurier, C. and the INSERM network on molecular abnormalities in von Willebrand disease. (2003) Two novel mutations, Q1053 H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased F VIII-binding capacity. Br. J. Haematol. 120, 627-632.
110. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc. New York Pathol. Soc. 24 (1924) 21-24
111. Baehr G., Klemperer P., and Schifrin A. An acute febrile anemia and thrombocytopenic purpura with diffuse platelet thromboses of capillaries and arterioles. Trans. Assoc. Am. Physician 65 (1936) 43-58
112. Neame P.B., Lechago J., Ling E.T., and Koval A. Thrombotic thrombocytopenic purpura: report of a case with disseminated intravascular platelet aggregation. Blood 42 (1973) 805-814
113. Asada Y., Sumiyoshi A., Hayashi T., Suzumiya J., and Kaketani K. Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb. Res. 38 (1985) 469-479
114. Moake J.L., Rudy C.K., Troll J.H., Weinstein M.J., Colannino N.M., Azocar J., Seder R.H., Hong S.L., and Deykin D. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombcytopenic purpura. N. Engl. J. Med. 307 (1982) 1432-1435
115. Moake J.L., and McPherson P.D. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am. J. Med. 87 (1989) 9N-15N
116. Sanders Jr. W.E., Reddick R.L., Nichols T.C., Brinkhous K.M., and Read M.S. Thrombotic thrombocytopenia induced in dogs and pigs: the role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura. Arterioscl. Thromb. Vas. Biol. 15 (1995) 793-800
117. Moake J.L., Turner N.A., Stathopoulos N.A., Nolasco L.H., and Hellums J.D. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J. Clin. Invest. 78 (1986) 1456-1461
118. Tsai H.-M., Nagel R.L., Hatcher V.B., and Sussman I.I. Multimeric composition of endothelial cell-derived von Willebrand factor. Blood 73 (1989) 2074-2076
119. Dent J.A., Berkowitz S.D., Ware J., Kasper C.K., and Ruggeri Z.M. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in Type IIA von Willebrand factor. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6306-6310
120. Dent J.A., Galbusera M., and Ruggeri Z.M. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J. Clin. Invest. 88 (1991) 774-782
121. Furlan M., Robles R., Affolter D., Meyer D., Baillod P., and Lämmle B. Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7503-7507
122. Frangos J.A., Moake J.L., Nolasco L., Phillips M.D., and McIntire L.V. Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells. Am. J. Physiol. 256 (1989) H1635-H1644
123. Tsai H.-M., Sussman I.I., and Nagel R.L. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 83 (1994) 2171-2179
124. Tsai H.-M. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87 (1996) 4235-4244
125. Furlan M., Robles R., and Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87 (1996) 4223-4234
126. van Mourik J.A., Bouma B.N., LaBruyère W.T., de Graaf S., and Mochtar I.A. Factor VIII, a series of homologous oligomers and a complex of two proteins. Thromb. Res. 4 (1974) 155-164
127. Fujikawa K., Suzuki H., MacMullen B., and Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98 (2001) 1662-1666
128. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., Yang A.Y., Siemieniak D.R., Stark K.R., Gruppo R., Sarode R., Shurin S.B., Chandrasekaran V., Stabler S.P., Sabio H., Bouhassira E.E., Upshaw Jr. J.D., Ginsburg D., and Tsai H.-M. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 (2001) 488-494
129. Plaimauer B., Zimmermann K., Völkel D., Antoine G., Kerschbaumer R., Jenab P., Furlan M., Gerritsen H., Lämmle B., Schwarz H.P., and Scheiflinger F. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS 13). Blood 100 (2002) 3626-3632
130. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., Krause M., Scharrer I., Aumann V., Mittler U., Solenthaler M., and Lämmle B. von Willebrand factor - cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N. Engl. J. Med. 339 (1998) 1578-1584
131. Tsai H.-M., and Chun-Yet Lian E. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N. Engl. J. Med. 339 (1998) 1585-1594
132. Yoo G., Blombäck M., Schenk-Gustafsson K., and He S. Decreased level of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin-induced platelet aggregation. Br. J. Haematol. 121 (2003) 123-129
133. Kokame K., Matsumoto M., Fujimura Y., and Miyata T. VWF73, a region from D1596 to R 1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood 103 (2004) 607-612
134. Dong J.-F., Moake J.L., Bernardo A., Fujikawa K., Ball C., Nolasco L., Lópes J.A., and Cruz M.A. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. J. Biol. Chem. 278 (2003) 29633-29639
135. Lópes J.A., and Dong J.-f. Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells. Semin. Hematol. 41 (2004) 15-23
136. Nishio K., Anderson P.J., Zheng X.L., and Sadler J.E. Binding of platelet glycoprotein 1bα to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS 13. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 10578-10583
137. Perrault C., Ajzenberg N., Legendre P., Rastegar-Lari G., Meyer D., Lopez J.A., and Baruch D. Modulation by heparin of the interaction of the A1 domain of von Willebrand factor with glycoprotein Ib. Blood 94 (1999) 4186-4194
138. Blombäck B., Blombäck M., Finkbeiner W., Holmgren A., Kowalska-Loth B., and Olovson G. Enzymatic reduction of disulfide bonds in fibrin-ogen by the thioredoxin system I. Identification of reduced bonds and studies on reoxidation process. Thromb. Res. 4 (1974) 55-75
139. Pimanda J.E., Ganderton T., Maekawa A., Yap C.L., Lawler J., Kershaw G., Chesterman C.N., and Hogg P.J. Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice. J. Biol. Chem. 279 (2004) 21439-21448
140. Blombäck B. Pehr Victor Edman: the solitary genius. In: Semenza G., and Turner A.J. (Eds). Selected Topics in the History of Biochemistry: Personal Recollections VII (Comprehensive Vol. 42) (2003), Elsevier Science BV 103-135